119 related articles for article (PubMed ID: 23886882)
1. Re: Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2013; 189: 867-870.
Singh I; Gautam L
J Urol; 2013 Oct; 190(4):1439-40. PubMed ID: 23886882
[No Abstract] [Full Text] [Related]
2. Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
Eggener S
Urol Oncol; 2014 Aug; 32(6):935-6. PubMed ID: 25087672
[TBL] [Abstract][Full Text] [Related]
3. Re: Complications after prostate biopsy: data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2011; 186: 1830-1834.
Ravi P; Sammon J; Meskawi M; Sun M; Karakiewicz PI; Trinh QD
J Urol; 2012 Aug; 188(2):677-8. PubMed ID: 22704450
[No Abstract] [Full Text] [Related]
4. Re: To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy: A. S. Kibel J Urol 2013; 189: 796-797.
Horan AH
J Urol; 2013 Sep; 190(3):1139. PubMed ID: 23583228
[No Abstract] [Full Text] [Related]
5. To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy.
Kibel AS
J Urol; 2013 Mar; 189(3):796-7. PubMed ID: 23246850
[No Abstract] [Full Text] [Related]
6. Reply by authors.
J Urol; 2013 Oct; 190(4):1440. PubMed ID: 23886879
[No Abstract] [Full Text] [Related]
7. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
J Urol; 2013 Mar; 189(3):867-70. PubMed ID: 23063634
[TBL] [Abstract][Full Text] [Related]
8. Reply by author.
J Urol; 2013 Sep; 190(3):1140. PubMed ID: 23770372
[No Abstract] [Full Text] [Related]
9. Cutting to the Core of the Issue: Emerging Strategies To Reduce Prostate Biopsy-Related Infections.
Chamberland RR
J Clin Microbiol; 2016 Oct; 54(10):2431-5. PubMed ID: 27147719
[TBL] [Abstract][Full Text] [Related]
10. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
[TBL] [Abstract][Full Text] [Related]
11. Complications after prostate biopsy: data from SEER-Medicare.
Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
J Urol; 2011 Nov; 186(5):1830-4. PubMed ID: 21944136
[TBL] [Abstract][Full Text] [Related]
12. Re: Factors predicting prostatic biopsy Gleason sum under grading: D. A. Stackhouse, L. Sun, F. R. Schroeck, J. Jayachandran, A. A. Caire, C. O. Acholo, C. N. Robertson, D. M. Albala, T. J. Polascik, C. F. Donatucci, K. E. Maloney and J. W. Moul J Urol 2009; 182: 118-124.
Labanaris AP; Kühn R; Zugor V
J Urol; 2010 Jan; 183(1):396-7; author reply 397-8. PubMed ID: 19945124
[No Abstract] [Full Text] [Related]
13. Re: The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer: S. Loeb, M. G. Sanda, D. L. Broyles, S. S. Shin, C. H. Bangma, J. T. Wei, A. W. Partin, G. G. Klee, K. M. Slawin, L. S. Marks, R. H. N. van Schaik, D. W. Chan, L. J. Sokoll, A. B. Cruz, I. A. Mizrahi and W. J. Catalona J Urol 2015;193:1163-1169.
Shah N; Ioffe V
J Urol; 2015 Dec; 194(6):1825-6. PubMed ID: 26354886
[No Abstract] [Full Text] [Related]
14. Re: Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program J. J. Tosoian, S. Loeb, A. Kettermann, P. Landis, D. J. Elliot, J. I. Epstein, A. W. Partin, H. B. Carter and L. J. Sokoll J Urol 2010; 183: 534-538.
Papatsoris A; Bourdoumis A; Chrisofos M
J Urol; 2010 Jul; 184(1):396-7. PubMed ID: 20488485
[No Abstract] [Full Text] [Related]
15. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
Stamatiou K; Alevizos A; Mariolis A; Sofras F
J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
[No Abstract] [Full Text] [Related]
16. [Transrectal needle biopsy of the prostate in diagnosis of prostate carcinoma].
Kliment J; Beseda O; Kalfa I
Bratisl Lek Listy; 1982 Jul; 78(1):100-6. PubMed ID: 7127158
[No Abstract] [Full Text] [Related]
17. Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann and J. Kleijnen, J Urol, 175: 1605-1612, 2006.
Eskicorapci SY; Tuncay L
J Urol; 2006 Dec; 176(6 Pt 1):2745; author reply 2745-6. PubMed ID: 17085209
[No Abstract] [Full Text] [Related]
18. Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur urol 2007;52:1663-9.
Boscolo-Berto R; Galfano A; Iafrate M
Eur Urol; 2008 Aug; 54(2):469-70; author reply 471. PubMed ID: 18299171
[No Abstract] [Full Text] [Related]
19. Repeat prostate needle biopsy: who needs it?
Ellis WJ; Brawer MK
J Urol; 1995 May; 153(5):1496-8. PubMed ID: 7536254
[TBL] [Abstract][Full Text] [Related]
20. Re: Felix K.-H. Chun, Markus Graefen, Alberto Briganti, Andrea Gallina, Julia Hopp, Michael W. Kattan, Hartwig Huland and Pierre I. Karakiewicz. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 2007;51:1236-43.
Stephan C; Meyer HA; Cammann H; Lein M; Loening SA; Jung K
Eur Urol; 2007 May; 51(5):1446-7; author reply 1448. PubMed ID: 17141943
[No Abstract] [Full Text] [Related]
[Next] [New Search]
